kind of wish they would send our analyst reports every week if this the result!
- Forums
- ASX - By Stock
- HLA
- Cannacord updated research - target price $1.45
Cannacord updated research - target price $1.45, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online